Stockreport

Sagimet Biosciences Announces Participation in Three Upcoming Investor Conferences [Yahoo! Finance]

Sagimet Biosciences Inc. - Series A  (SGMT) 
PDF biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that management will participate in thre [Read more]